Business Context and Reporting Period
This Form 6-K is a Current Report filed by ARGENX SE, a foreign private issuer headquartered in Breda, the Netherlands. The report covers the month of May 2019, specifically referencing a press release issued on May 9, 2019 (Exhibit 99.1).
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to incorporate a press release by reference and does not contain a financial statement or tabular data.
Material Changes
The filing does not disclose material changes in financial position or operations compared to prior periods. The document's primary function is to notify the SEC of the May 9, 2019 press release and incorporate that information into the Company's Registration Statements on Forms F-3 and S-8.
Guidance, Outlook, and Risks
Specific guidance, outlook, management commentary, risks, contingencies, or unusual items are not detailed within the body of this Form 6-K. These details are contained within the attached press release (Exhibit 99.1), which is incorporated by reference but not reproduced in the provided text.
Key Facts for Investor Verification
- Verify the content of the May 9, 2019 press release (Exhibit 99.1) for specific operational or clinical updates, as the Form 6-K itself contains no substantive data.
- Confirm the incorporation of this report into Registration Statements File No. 333-225370 (Form F-3) and File No. 333-225375 (Form S-8).
- Note that the report was signed by Dirk Beeusaert, General Counsel, on May 9, 2019.